{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:08:31Z","timestamp":1790885311841,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003437","name":"El Paso Community Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.neuroscience.2019.05.029","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:01:29Z","timestamp":1558612889000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces \u03b1-Synuclein Pathology in Parkinsonian GM2 +\/\u2212 Mice"],"prefix":"10.1016","volume":"411","author":[{"given":"Guadalupe","family":"Vidal-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Najera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie D.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Gil-Tommee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Vargas-Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Diaz-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth G.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2019.05.029_bb0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.25.11.1045","article-title":"Decreased myelin basic protein content of the aged human brain","volume":"25","author":"Ansari","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0015","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.26702","article-title":"Similar alpha-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls","volume":"31","author":"Antunes","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0020","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0022-5347(05)67048-6","article-title":"Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms","volume":"164","author":"Araki","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/elps.201100335","article-title":"Bleach gel: a simple agarose gel for analyzing RNA quality","volume":"33","author":"Aranda","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","article-title":"Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects","volume":"571","author":"Beach","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0891988710383572","article-title":"The genetics of Parkinson disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0045","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/NEN.0000000000000137","article-title":"Early and persistent expression of phosphorylated alpha-synuclein in the enteric nervous system of A53T mutant human alpha-synuclein transgenic mice","volume":"73","author":"Bencsik","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/jnc.13570","article-title":"The contribution of alpha synuclein to neuronal survival and function - implications for Parkinson's disease","volume":"137","author":"Benskey","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nn902","article-title":"Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1","volume":"5","author":"Birder","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0060","doi-asserted-by":"crossref","first-page":"F1369","DOI":"10.1152\/ajprenal.00072.2015","article-title":"Evaluation of voiding assays in mice: impact of genetic strains and sex","volume":"308","author":"Bjorling","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2019.05.029_bb0065","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1353-8020(11)70004-9","article-title":"Autosomal recessive parkinsonism","volume":"18","author":"Bonifati","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11065-010-9143-9","article-title":"The cerebellum and basal ganglia are interconnected","volume":"20","author":"Bostan","year":"2010","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0075","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1073\/pnas.1000496107","article-title":"The basal ganglia communicate with the cerebellum","volume":"107","author":"Bostan","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0080","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172348","article-title":"Elevated GM3 plasma concentration in idiopathic Parkinson's disease: a lipidomic analysis","volume":"12","author":"Chan","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(11)70227-7","article-title":"Modelling of Parkinson's disease in mice","volume":"10","author":"Chesselet","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2000.7504","article-title":"A functional role for complex gangliosides: motor deficits in GM2\/GD2 synthase knockout mice","volume":"166","author":"Chiavegatto","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0110","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12311-013-0468-9","article-title":"Characteristics of neurogenic voiding dysfunction in cerebellar stroke: a cross-sectional, retrospective video urodynamic study","volume":"12","author":"Chou","year":"2013","journal-title":"Cerebellum"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0115","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1098\/rspb.2009.0664","article-title":"Dynamic arm swinging in human walking","volume":"276","author":"Collins","year":"2009","journal-title":"Proceedings Biological sciences \/ The Royal Society"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson's disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0125","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1006\/exnr.1999.7225","article-title":"Alterations in nigrostriatal dopaminergic function within BDNF mutant mice","volume":"160","author":"Dluzen","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061988","article-title":"Fingolimod phosphate attenuates oligomeric amyloid beta-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons","volume":"8","author":"Doi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jnc.12481","article-title":"Non-motor parkinsonian pathology in aging A53T alpha-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function","volume":"128","author":"Farrell","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0145","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0150","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/nen.0b013e3180517454","article-title":"Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease","volume":"66","author":"Fumimura","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2018.10.014","article-title":"Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder","volume":"311","author":"Gil-Tommee","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/cns.12796","article-title":"Fingolimod-improved axonal and myelin integrity of white matter tracts associated with multiple sclerosis-related functional impairments","volume":"24","author":"Gurevich","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0165","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1212\/WNL.0000000000005903","article-title":"Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease","volume":"91","author":"Hacker","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.expneurol.2014.10.010","article-title":"GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model","volume":"263","author":"Hadaczek","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0175","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/dneu.20978","article-title":"Autonomic dysfunction and plasticity in micturition reflexes in human alpha-synuclein mice","volume":"72","author":"Hamill","year":"2012","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0180","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jnc.12195","article-title":"Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms","volume":"125","author":"Harauz","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0185","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.juro.2007.12.039","article-title":"Voiding pattern analysis as a surrogate for cystometric evaluation in uroplakin II knockout mice","volume":"179","author":"Hodges","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.parkreldis.2010.08.022","article-title":"Multi-organ autonomic dysfunction in Parkinson disease","volume":"17","author":"Jain","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0195","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2125.2003.02065.x","article-title":"Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects","volume":"57","author":"Kovarik","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0200","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00401-007-0320-8","article-title":"Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach","volume":"115","author":"Kuhlmann","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0205","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ng1095","article-title":"Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination","volume":"33","author":"Lappe-Siefke","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0210","doi-asserted-by":"crossref","DOI":"10.3791\/55361","article-title":"Recombinant alpha- beta- and gamma-Synucleins stimulate protein phosphatase 2A catalytic subunit activity in cell free assays","author":"Lek","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0215","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1074\/jbc.M110.100867","article-title":"Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo","volume":"285","author":"Lou","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0220","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi061749a","article-title":"GM1 specifically interacts with alpha-synuclein and inhibits fibrillation","volume":"46","author":"Martinez","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0225","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00401-018-1832-0","article-title":"Interaction of amyloidogenic proteins in pancreatic beta cells from subjects with synucleinopathies","volume":"135","author":"Martinez-Valbuena","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0230","series-title":"Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(\u22124-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Drug metabolism and disposition: the biological fate of chemicals","first-page":"1480","volume":"Vol. 34","author":"Meno-Tetang","year":"2006"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0235","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/mds.26720","article-title":"Arm swing as a potential new prodromal marker of Parkinson's disease","volume":"31","author":"Mirelman","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0240","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00018-005-5188-y","article-title":"Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins","volume":"62","author":"Mocchetti","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1615\/CritRevNeurobiol.v16.i12.50","article-title":"Brain-derived neurotrophic factor activation of TrkB protects neurons from HIV-1\/gp120-induced cell death","volume":"16","author":"Mocchetti","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0250","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518761360","article-title":"The convergence of dopamine and \u03b1-Synuclein: implications for Parkinson's disease","volume":"12","author":"Mor","year":"2018","journal-title":"J Exp Neurosci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature09614","article-title":"Myelination and support of axonal integrity by glia","volume":"468","author":"Nave","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.12688\/f1000research.10100.1","article-title":"Recent advances in treating Parkinson's disease","volume":"6","author":"Oertel","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1742-2094-11-61","article-title":"Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord","volume":"11","author":"Ohmi","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0270","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mds.27392","article-title":"Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson's disease pathology severity","volume":"33","author":"Ortuno-Lizaran","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0275","first-page":"39","article-title":"Implication of alpha-Synuclein phosphorylation at S129 in Synucleinopathies: what have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J Park Dis"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0280","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3390\/nu7053891","article-title":"The role of Gangliosides in neurodevelopment","volume":"7","author":"Palmano","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0285","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0290","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1471-4159.2004.02423.x","article-title":"Could a loss of alpha-synuclein function put dopaminergic neurons at risk?","volume":"89","author":"Perez","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0295","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0300","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10555-008-9119-x","article-title":"Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias","volume":"27","author":"Perrotti","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0305","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0310","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1242\/jeb.024927","article-title":"Control and function of arm swing in human walking and running","volume":"212","author":"Pontzer","year":"2009","journal-title":"J Exp Biol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0315","series-title":"Nova Publishers - Alpha-Synuclein","first-page":"51","article-title":"Potential contribution of alpha-synuclein dysregulation to Parkinson's disease pathology","author":"Porras","year":"2014"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0320","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","article-title":"Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction","volume":"584","author":"Posse de Chaves","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0325","first-page":"658083","article-title":"Limitations of animal models of Parkinson's disease","volume":"2011","author":"Potashkin","year":"2010","journal-title":"Park Dis"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0330","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s11064-016-2125-4","article-title":"FTY720 attenuates 6-OHDA-associated dopaminergic degeneration in cellular and mouse Parkinsonian models","volume":"42","author":"Ren","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0335","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1172\/JCI97837","article-title":"Role of proNGF\/p75 signaling in bladder dysfunction after spinal cord injury","volume":"128","author":"Ryu","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0340","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s40265-014-0264-y","article-title":"Fingolimod: a review of its use in relapsing-remitting multiple sclerosis","volume":"74","author":"Sanford","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0345","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.febslet.2009.10.011","article-title":"Brain gangliosides in axon-myelin stability and axon regeneration","volume":"584","author":"Schnaar","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0350","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/WNL.50.6.1630","article-title":"Parkinson's disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study","volume":"50","author":"Schneider","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2010.02.009","article-title":"GM1 ganglioside in Parkinson's disease: results of a five year open study","volume":"292","author":"Schneider","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0360","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2017.01.028","article-title":"FTY720 (Fingolimod) reverses alpha-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells","volume":"117","author":"Segura-Ulate","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0365","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","article-title":"Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects","volume":"96","author":"Sheikh","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0370","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.84.14_supplement.P1.159","article-title":"Fingolimod up-regulates BDNF expression within the CNS and Down-regulates tissue pathology in a pre-clinical model of chronic Neuroinflammation (P1.159)","volume":"84","author":"Smith","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0375","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3389\/fnhum.2015.00715","article-title":"Balance impairments after brachial plexus injury as assessed through clinical and Posturographic evaluation","volume":"9","author":"Souza","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0380","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/REVNEURO.1994.5.4.293","article-title":"The adrenal medulla and Parkinson's disease","volume":"5","author":"Stoddard","year":"1994","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0385","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12031-008-9100-8","article-title":"Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)\u2212\/\u2212 mice","volume":"36","author":"Studeny","year":"2008","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0390","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/glycob\/cws103","article-title":"Biosynthesis of the major brain gangliosides GD1a and GT1b","volume":"22","author":"Sturgill","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0395","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000226119","article-title":"Cerebellar Ataxia and overactive bladder after encephalitis affecting the cerebellum","volume":"1","author":"Sugiyama","year":"2009","journal-title":"Case reports in neurology"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0400","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2006.04146.x","article-title":"Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells","volume":"99","author":"Tehranian","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0405","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.conb.2010.08.022","article-title":"Basal ganglia contributions to motor control: a vigorous tutor","volume":"20","author":"Turner","year":"2010","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0410","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/ml500128g","article-title":"Novel FTY720-based compounds stimulate neurotrophin expression and phosphatase activity in dopaminergic cells","volume":"5","author":"Vargas-Medrano","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0415","doi-asserted-by":"crossref","first-page":"20811","DOI":"10.1074\/jbc.M116.744029","article-title":"FTY720\/Fingolimod reduces synucleinopathy and improves gut motility in A53T mice: contributions of pro-brain-derived neurotrophic factor (pro-BDNF) and mature BDNF","volume":"291","author":"Vidal-Martinez","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0420","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0300-9084(01)01308-6","article-title":"Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration","volume":"83","author":"Vyas","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0425","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neures.2003.10.002","article-title":"Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline","volume":"48","author":"Wang","year":"2004","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0430","doi-asserted-by":"crossref","first-page":"14011","DOI":"10.1074\/jbc.M901310200","article-title":"14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria","volume":"284","author":"Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0435","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","article-title":"Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein","volume":"67","author":"Waxman","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0440","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson's disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0445","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s11064-011-0437-y","article-title":"Mice lacking major brain gangliosides develop parkinsonism","volume":"36","author":"Wu","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0450","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jnr.23090","article-title":"Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans","volume":"90","author":"Wu","year":"2012","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0455","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1073\/pnas.98.1.307","article-title":"Cerebellar neurons lacking complex gangliosides degenerate in the presence of depolarizing levels of potassium","volume":"98","author":"Wu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0460","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neuroscience.2012.01.028","article-title":"Lewy-like aggregation of alpha-synuclein reduces protein phosphatase 2A activity in vitro and in vivo","volume":"207","author":"Wu","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0465","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/brain\/aws360","article-title":"The cerebellum in Parkinson's disease","volume":"136","author":"Wu","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0470","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3892\/ijmm.2013.1486","article-title":"Age-related decline of myelin proteins is highly correlated with activation of astrocytes and microglia in the rat CNS","volume":"32","author":"Xie","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0475","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuroscience.2015.10.013","article-title":"Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720)","volume":"311","author":"Yazdi","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0480","doi-asserted-by":"crossref","first-page":"F1296","DOI":"10.1152\/ajprenal.00074.2014","article-title":"Spontaneous voiding by mice reveals strain-specific lower urinary tract function to be a quantitative genetic trait","volume":"306","author":"Yu","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.neuroscience.2019.05.029_bb0485","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1096\/fj.201600751r","article-title":"Neuroprotective effects of fingolimod in mouse models of Parkinson's disease","volume":"31","author":"Zhao","year":"2017","journal-title":"FASEB J"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219303525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219303525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:49:01Z","timestamp":1759679341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452219303525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":97,"alternative-id":["S0306452219303525"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2019.05.029","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces \u03b1-Synuclein Pathology in Parkinsonian GM2+\/\u2212 Mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2019.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of IBRO.","name":"copyright","label":"Copyright"}]}}